1
|
Zhou ZR, Huang W, Liu KJ, Lin FL, Wang XL, Wang F, Jiang RW. Soluble Expression, One-Step Purification and Characterization of Recombinant Human Growth Hormone Fused with ompA3 in Escherichia coli. Protein Pept Lett 2021; 28:533-542. [PMID: 33172365 DOI: 10.2174/0929866527666201110123426] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2020] [Revised: 09/17/2020] [Accepted: 09/19/2020] [Indexed: 12/21/2022]
Abstract
BACKGROUND Human growth hormone (hGH) is the first recombinant protein approved for the treatment of human growth hormone deficiency. However, expression in inclusion bodies and low expression levels are enormous challenges for heterologous expression of hGH in Escherichia coli. OBJECTIVE To increase the soluble expression of recombinant hGH with correct folding in E. coli. METHODS We constructed a new recombinant expression plasmid containing the coding sequence of the outer membrane protein A (ompA3) which was used for the expression in Transetta (DE3) E. coli. In order to simplify the purification process and cleavage of recombinant proteins, the fusion sequence should contain hexahistidine-tag (His6) and enterokinase recognition sites (D4K). The effect of different expression conditions on recombinant hGH expression was optimized in flask cultivations. Furthermore, the periplasmic solution containing soluble hGH was purified by Ni-NTA affinity chromatography. Circular dichroism (CD), western blot and mass spectrometry analyses were used to characterize the protein. Moreover, the growth-promoting effect of the purified hGH was also evaluated by cell proliferation assay. RESULTS High-level expression (800 μg/mL) was achieved by induction with 0.5 mM IPTG at 30°C for 10 hours. The purity of hGH was over 90%. The immunological activity, secondary structure and molecular weight of the purified hGH were consistent with native hGH. The purified hGH was found to promote the growth of MC3T3-E1 cells, and was found to show the highest activity at a concentration of 100 ng/mL. CONCLUSION Our research provides a feasible and convenient method for the soluble expression of recombinant hGH in E. coli, and may lay a foundation for the production and application of hGH in the industry.
Collapse
Affiliation(s)
- Zhen-Ru Zhou
- Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chines Ministry of Education, Jinan University, Guangzhou 510632, China
| | - Wei Huang
- Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chines Ministry of Education, Jinan University, Guangzhou 510632, China
| | - Kang-Jia Liu
- Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chines Ministry of Education, Jinan University, Guangzhou 510632, China
| | - Fo-Lan Lin
- Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chines Ministry of Education, Jinan University, Guangzhou 510632, China
| | - Xiao-Lu Wang
- Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chines Ministry of Education, Jinan University, Guangzhou 510632, China
| | - Feng Wang
- Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chines Ministry of Education, Jinan University, Guangzhou 510632, China
| | - Ren-Wang Jiang
- Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chines Ministry of Education, Jinan University, Guangzhou 510632, China
| |
Collapse
|
2
|
Recent Advancements of UF-Based Separation for Selective Enrichment of Proteins and Bioactive Peptides—A Review. APPLIED SCIENCES-BASEL 2021. [DOI: 10.3390/app11031078] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
Proteins are one of the primary building blocks that have significant functional properties to be applied in food and pharmaceutical industries. Proteins could be beneficial in their concentrated products or isolates, of which membrane-based filtration methods such as ultrafiltration (UF) encompass application in broad spectra of protein sources. More importantly, selective enrichment by UF is of immense interest due to the presence of antinutrients that may dominate their perspicuous bioactivities. UF process is primarily obstructed by concentration polarization and fouling; in turn, a trade-off between productivity and selectivity emerges, especially when pure isolates are an ultimate goal. Several factors such as operating conditions and membrane equipment could leverage those pervasive contributions; therefore, UF protocols should be optimized for each unique protein mixture and mode of configuration. For instance, employing charged UF membranes or combining UF membranes with electrodialysis enables efficient separation of proteins with a similar molecular weight, which is hard to achieve by the conventional UF membrane. Meanwhile, some proposed strategies, such as utilizing ultrasonic waves, tuning operating conditions, and modifying membrane surfaces, can effectively mitigate fouling issues. A plethora of advancements in UF, from their membrane material modification to the arrangement of new configurations, contribute to the quest to actualize promising potentials of protein separation by UF, and they are reviewed in this paper.
Collapse
|
3
|
Sun L, Chen Q, Lu H, Wang J, Zhao J, Li P. Electrodialysis with porous membrane for bioproduct separation: Technology, features, and progress. Food Res Int 2020; 137:109343. [DOI: 10.1016/j.foodres.2020.109343] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2019] [Revised: 05/15/2020] [Accepted: 05/18/2020] [Indexed: 11/26/2022]
|
4
|
Lee SY, Han JH, Lee EK, Kim YK, Hwang SA, Lee SH, Kim M, Cho GY, Hwang JH, Kim SJ, Yoo JG, Cho SK, Lee KJ, Cho WK. Structural and functional characterization of recombinant human growth hormone isolated from transgenic pig milk. PLoS One 2020; 15:e0236788. [PMID: 32735629 PMCID: PMC7394428 DOI: 10.1371/journal.pone.0236788] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2019] [Accepted: 07/14/2020] [Indexed: 12/04/2022] Open
Abstract
This study aimed to establish and reproduce transgenic pigs expressing human growth hormone (hGH) in their milk. We also aimed to purify hGH from the milk, to characterize the purified protein, and to assess the potential of our model for mass production of therapeutic proteins using transgenic techniques. Using ~15.5 L transgenic pig milk, we obtained proteins with ≥ 99% purity after three pre-treatments and five column chromatography steps. To confirm the biosimilarity of our milk-derived purified recombinant hGH (CGH942) with commercially available somatropin (Genotropin), we performed spectroscopy, structural, and biological analyses. We observed no difference between the purified protein and Genotropin samples. Furthermore, rat models were used to assess growth promotion potential. Our results indicate that CGH942 promotes growth, by increasing bone development and body weight. Toxicity assessments revealed no abnormal findings after 4 weeks of continuous administration and 2 weeks of recovery. The no-observed-adverse-effect level for both males and females was determined to be 0.6 mg/kg/day. Thus, no toxicological differences were observed between commercially available somatropin and CGH942 obtained from transgenic pig milk. In conclusion, we describe a transgenic technique using pigs, providing a new platform to produce human therapeutic proteins.
Collapse
Affiliation(s)
- So-Young Lee
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
- * E-mail:
| | - Joo-Hee Han
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
- Department of Animal Science, College of Natural Resources and Life Science, Pusan National University, Miryang-si, Gyeongsangnam-do, Korea
| | - Eun-Kyeong Lee
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
| | - Young Kyu Kim
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
| | - Seo-Ah Hwang
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
| | - Sung-Hyun Lee
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
| | - Maria Kim
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
| | - Gye Yoon Cho
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
| | - Jae-Ha Hwang
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
| | - Su-Jin Kim
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
| | - Jae-Gyu Yoo
- Animal Diseases and Biosecurity Team, National Institute of Animal Science, Rural Development Administration, Wanju-gun, Jeollabuk-do, Korea
| | - Seong-Keun Cho
- Department of Animal Science, College of Natural Resources and Life Science, Pusan National University, Miryang-si, Gyeongsangnam-do, Korea
| | - Kyung-Ju Lee
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
| | - Weon-Ki Cho
- CHO-A Biotechnology Research Institute, CHO-A Pharmaceutical Company, Yeoju-si, Gyeonggi-do, Korea
| |
Collapse
|
5
|
Levarski Z, Šoltýsová A, Krahulec J, Stuchlík S, Turňa J. High-level expression and purification of recombinant human growth hormone produced in soluble form in Escherichia coli. Protein Expr Purif 2014; 100:40-7. [DOI: 10.1016/j.pep.2014.05.003] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2014] [Revised: 05/07/2014] [Accepted: 05/12/2014] [Indexed: 11/24/2022]
|
6
|
Prokaryotic soluble overexpression and purification of bioactive human growth hormone by fusion to thioredoxin, maltose binding protein, and protein disulfide isomerase. PLoS One 2014; 9:e89038. [PMID: 24614134 PMCID: PMC3948679 DOI: 10.1371/journal.pone.0089038] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2013] [Accepted: 01/14/2014] [Indexed: 11/25/2022] Open
Abstract
Human growth hormone (hGH) is synthesized by somatotroph cells of the anterior pituitary gland and induces cell proliferation and growth. This protein has been approved for the treatment of various conditions, including hGH deficiency, chronic renal failure, and Turner syndrome. Efficient production of hGH in Escherichia coli (E. coli) has proven difficult because the E. coli-expressed hormone tends to aggregate and form inclusion bodies, resulting in poor solubility. In this study, seven N-terminal fusion partners, hexahistidine (His6), thioredoxin (Trx), glutathione S-transferase (GST), maltose-binding protein (MBP), N-utilization substance protein A (NusA), protein disulfide bond isomerase (PDI), and the b′a′ domain of PDI (PDIb′a′), were tested for soluble overexpression of codon-optimized hGH in E. coli. We found that MBP and hPDI tags significantly increased the solubility of the hormone. In addition, lowering the expression temperature to 18°C also dramatically increased the solubility of all the fusion proteins. We purified hGH from MBP-, PDIb′a′-, or Trx-tagged hGH expressed at 18°C in E. coli using simple chromatographic techniques and compared the final purity, yield, and activity of hGH to assess the impact of each partner protein. Purified hGH was highly pure on silver-stained gel and contained very low levels of endotoxin. On average, ∼37 mg, ∼12 mg, and ∼7 mg of hGH were obtained from 500 mL-cell cultures of Trx-hGH, MBP-hGH, and PDIb′a′-hGH, respectively. Subsequently, hGH was analyzed using mass spectroscopy to confirm the presence of two intra-molecular disulfide bonds. The bioactivity of purified hGHs was demonstrated using Nb2-11 cell.
Collapse
|
7
|
Saraswat M, Musante L, Ravidá A, Shortt B, Byrne B, Holthofer H. Preparative purification of recombinant proteins: current status and future trends. BIOMED RESEARCH INTERNATIONAL 2013; 2013:312709. [PMID: 24455685 PMCID: PMC3877584 DOI: 10.1155/2013/312709] [Citation(s) in RCA: 93] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/23/2013] [Accepted: 11/17/2013] [Indexed: 12/18/2022]
Abstract
Advances in fermentation technologies have resulted in the production of increased yields of proteins of economic, biopharmaceutical, and medicinal importance. Consequently, there is an absolute requirement for the development of rapid, cost-effective methodologies which facilitate the purification of such products in the absence of contaminants, such as superfluous proteins and endotoxins. Here, we provide a comprehensive overview of a selection of key purification methodologies currently being applied in both academic and industrial settings and discuss how innovative and effective protocols such as aqueous two-phase partitioning, membrane chromatography, and high-performance tangential flow filtration may be applied independently of or in conjunction with more traditional protocols for downstream processing applications.
Collapse
Affiliation(s)
- Mayank Saraswat
- Centre for Bioanalytical Sciences (CBAS), Dublin City University (DCU), Dublin 9, Ireland
| | - Luca Musante
- Centre for Bioanalytical Sciences (CBAS), Dublin City University (DCU), Dublin 9, Ireland
| | - Alessandra Ravidá
- Centre for Bioanalytical Sciences (CBAS), Dublin City University (DCU), Dublin 9, Ireland
| | - Brian Shortt
- Centre for Bioanalytical Sciences (CBAS), Dublin City University (DCU), Dublin 9, Ireland
| | - Barry Byrne
- Centre for Bioanalytical Sciences (CBAS), Dublin City University (DCU), Dublin 9, Ireland
| | - Harry Holthofer
- Centre for Bioanalytical Sciences (CBAS), Dublin City University (DCU), Dublin 9, Ireland
| |
Collapse
|
8
|
Efficient expression and secretion of recombinant human growth hormone in the methylotrophic yeast Pichia pastoris: potential applications for other proteins. Biotechnol Appl Biochem 2009; 54:197-205. [PMID: 19814714 DOI: 10.1042/ba20090179] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
A simple high yielding process for the production of rhGH (recombinant human growth hormone) in the Pichia pastoris system is described. The approach adopted the addition of surfactants during fermentation along with methanol induction. A Pichia integrant harbouring multiple-copy, non-codon-optimized hGH showed poor expression in complex and defined media. Inclusion of the surfactants Tween 20 or Tween 80 during induction enhanced the expression levels significantly in shake flask studies. The combination of 2 litres of basal salt medium and Tween 20 in a bioreactor culminated in 3 x 10(4)-fold elevated expression of the protein (approximately 500 mg/l) as estimated by ELISA. SDS/PAGE and Western-blot analyses revealed that the Pichia-derived rhGH migrated as a single band with a molecular mass of approximately 22 kDa and had the same immunoreactivity as native commercial rhGH. Analysis of Pichia-derived purified rhGH and commercial rhGH on an Agilent 2100 Bioanalyzer revealed overlapping peaks displaying authentic N-terminal processing of Pichia-derived rhGH, which was further confirmed by N-terminal sequencing. In addition, matrix-assisted laser-desorption ionization-time of flight analysis of the protein confirmed its authenticity. These results indicate that the P. pastoris expression system can be effective in the production of rhGH at commercially relevant levels.
Collapse
|
9
|
Wasinger V, Ly L, Fitzgerald A, Walsh B. Prefractionation, enrichment, desalting and depleting of low volume and low abundance proteins and peptides using the MF10. Methods Mol Biol 2008; 424:257-275. [PMID: 18369868 DOI: 10.1007/978-1-60327-064-9_21] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
The success of proteomics relies heavily in the ability to characterize very diverse species of proteins. This diversity stems from a proteins physicochemical properties, its copy number and abundance and its association with other proteins. Prefractionation and simplification of biological samples prior to downstream MS analysis is showing some virtue in obtaining greater depth of protein analysis. The MicroFlow MF10 is a prefractionation device for low volume, low abundance complex samples that can also enrich for very specific species of proteins based on charge and/or size either in native or denaturing format. It has also been used to desalt and deplete samples of contaminating ions or proteins. Although this instrument is only in its infancy in terms of exploring its capabilities, the technology has been used successfully for the fractionation of plasma proteins Wasinger(1), Omenn GS(2), as well as purification of human growth hormone Catzel D(3) antibodies Cheung(4) and IgY Gee(5) and other complex samples.
Collapse
|
10
|
Ranke MB. New preparations comprising recombinant human growth hormone: deliberations on the issue of biosimilars. HORMONE RESEARCH 2007; 69:22-8. [PMID: 18057913 DOI: 10.1159/000111791] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/04/2007] [Accepted: 08/03/2007] [Indexed: 11/19/2022]
Abstract
Manufactured recombinant human GH (rhGH) has been available for more than 25 years. In the meantime, the GH produced by various manufacturers has been approved for application in replacement therapy in children and adults with GH deficiency or a number of disorders involving small stature in children. Until recently approval for each individual diagnosis was only granted after extensive studies on the long-term efficacy (e.g. adult height reached) and safety of the various products. Meanwhile, the European approving agency, the European Medicines Evaluation Agency (EMEA), has relinquished this restrictive stance. Thus, new rhGH preparations can count on gaining approval for existing indications even without conducting standard clinical studies of their efficacy and safety for each of these indications. The EMEA's reconsideration is apparently based on the rationale that recombinant GH can, in effect, be considered equivalent to the tried and tested preparations in wide use, provided certain specifications are met. The term 'biosimilars' was coined to denote the similarities between the products rather than their parity, as is the case with generics for instance. The higher complexity of biopharmaceuticals relates not only to the substances themselves but also to the manufacturing process. It is generally believed that modifications to a manufacturing process - which are a prerequisite for a patent - may cause modifications of the active substance which then may lead to different long-term effects. Thus, the term 'biosimilar' does not indicate that complex biopharmaceuticals deriving from the same substance are entirely identical, nor does the approval of a 'biosimilar' ensure this. The factual information provided here is offered towards clarification of some uncertainties and as a contribution towards resolving open questions relating to the topic of biosimilars. The final choice of product to be prescribed must be made by the informed, independent physician.
Collapse
Affiliation(s)
- Michael B Ranke
- Paediatric Endocrinology Section, University Hospital for Children and Adolescents, Tubingen, Germany
| |
Collapse
|
11
|
Catzel D, Chin DY, Stanton PG, Gray PP, Mahler SM. Fractionation of follicle stimulating hormone charge isoforms in their native form by preparative electrophoresis technology. J Biotechnol 2006; 122:73-85. [PMID: 16198015 DOI: 10.1016/j.jbiotec.2005.08.026] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2005] [Revised: 08/02/2005] [Accepted: 08/24/2005] [Indexed: 11/29/2022]
Abstract
Complex glycoprotein biopharmaceuticals, such as follicle stimulating hormone (FSH), erythropoietin and tissue plasminogen activator consist of a range of charge isoforms due to the extent of sialic acid capping of the glycoprotein glycans. Sialic acid occupies the terminal position on the oligosaccharide chain, masking the penultimate sugar residue, galactose from recognition and uptake by the hepatocyte asialoglycoprotein receptor. It is therefore well established that the more acidic charge isoforms of glycoprotein biopharmaceuticals have higher in vivo potencies than those of less acidic isoforms due to their longer serum half-life. Current strategies for manipulating glycoprotein charge isoform profile involve cell engineering or altering bioprocesss parameters to optimise expression of more acidic or basic isoforms, rather than downstream separation of isoforms. A method for the purification of a discrete range of bioactive recombinant human FSH (rhFSH) charge isoforms based on Gradiflowtrade mark preparative electrophoresis technology is described. Gradiflowtrade mark electrophoresis is scaleable, and incorporation into glycoprotein biopharmaceutical production bioprocesses as a potential final step facilitates the production of biopharmaceutical preparations of improved in vivo potency.
Collapse
Affiliation(s)
- Dallia Catzel
- Bioengineering Centre, School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia
| | | | | | | | | |
Collapse
|
12
|
Suck K, Walter J, Menzel F, Tappe A, Kasper C, Naumann C, Zeidler R, Scheper T. Fast and efficient protein purification using membrane adsorber systems. J Biotechnol 2006; 121:361-7. [PMID: 16159680 DOI: 10.1016/j.jbiotec.2005.07.023] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2005] [Revised: 07/11/2005] [Accepted: 07/26/2005] [Indexed: 11/28/2022]
Abstract
The purification of proteins from complex cell culture samples is an essential step in proteomic research. Traditional chromatographic methods often require several steps resulting in time consuming and costly procedures. In contrast, protein purification via membrane adsorbers offers the advantage of fast and gentle but still effective isolation. In this work, we present a new method for purification of proteins from crude cell extracts via membrane adsorber based devices. This isolation procedure utilises the membranes favourable pore structure allowing high flow rates without causing high back pressure. Therefore, shear stress to fragile structures is avoided. In addition, mass transfer takes place through convection rather than diffusion, thus allowing very rapid separation processes. Based on this membrane adsorber technology the separation of two model proteins, human serum albumin (HSA) and immungluboline G (IgG) is shown. The isolation of human growth hormone (hGH) from chinese hamster ovary (CHO) cell culture supernatant was performed using a cation exchange membrane. The isolation of the enzyme penicillin acylase from the crude Escherichia coli supernatant was achieved using an anion exchange spin column within one step at a considerable purity. In summary, the membrane adsorber devices have proven to be suitable tools for the purification of proteins from different complex cell culture samples.
Collapse
Affiliation(s)
- Kirstin Suck
- Institut für Technische Chemie der Universität Hannover, Callinstrasse 3, D-30167 Hannover, Germany
| | | | | | | | | | | | | | | |
Collapse
|
13
|
|